MS-Specific Internet-Based Therapy Program Can Cut Depressive Symptoms
TUESDAY, Oct. 17, 2023 (HealthDay News) — A multiple sclerosis (MS)-specific internet-based cognitive behavioral therapy (iCBT) program can reduce depressive symptoms among patients with MS, according to a study published in the October issue of The …
Learn MoreSociodemographic Factors Before MS Diagnosis Tied to Disease Severity
FRIDAY, Sept. 29, 2023 (HealthDay News) — Education, income, and marital status prior to multiple sclerosis (MS) onset are associated with future symptom and disability severity, according to a study published online Sept. 26 in JAMA Network Open.Ann…
Learn MoreEl tratamiento con células madre detiene la esclerosis múltiple en algunos pacientes
JUEVES, 28 de septiembre de 2023 (HealthDay News) — Un nuevo estudio está fortaleciendo la evidencia de que los trasplantes de células madre pueden ser altamente efectivos para algunas personas con esclerosis múltiple (EM), logrando que la enfermedad…
Learn MoreStem Cell Treatment Halts MS for Some Patients
WEDNESDAY, Sept. 27, 2023 (HealthDay News) — A new study is strengthening the evidence that stem cell transplants can be highly effective for some people with multiple sclerosis — sending the disease into remission for years, and sometimes reversing…
Learn MoreEmotional Issues Could Be Early Sign of MS
WEDNESDAY, Sept. 27, 2023 (HealthDay News) — A newer understanding of multiple sclerosis (MS) suggests that psychiatric conditions like anxiety and depression may emerge long before classic MS symptoms.“For a long time, it was thought that MS only re…
Learn MoreaHSCT Beneficial for Most Patients With Relapsing-Remitting MS
TUESDAY, Sept. 26, 2023 (HealthDay News) — Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most patients, according to a study publishe…
Learn MoreGene Test Spots Those Vulnerable to Rare but Severe Side Effect of Drugs for MS, Other Conditions
WEDNESDAY, Sept. 13, 2023 (HealthDay News) — A large number of drugs used to treat everything from multiple sclerosis to blood cancers to rheumatoid arthritis may cause a rare but often-fatal condition called progressive multifocal leukoencephalopath…
Learn MoreFirst Biosimilar Approved to Treat Multiple Sclerosis
FRIDAY, Aug. 25, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announc…
Learn MorePatients Say Ketogenic Diet Aids Multiple Sclerosis Symptoms
MONDAY, Aug. 21, 2023 (HealthDay News) — Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition.Emma Wetmore, from University of Virginia in Charl…
Learn MoreFatigue Correlates With Disability in Patients With Relapsing-Remitting MS
MONDAY, Aug. 14, 2023 (HealthDay News) — A lower disability rate, better physical condition, and higher daily-living activity predict lower fatigue levels in patients with relapsing-remitting multiple sclerosis (RRMS), according to a study published …
Learn More